News

Background Smoking is a significant risk factor for neurological disorders, yet its global impact on these conditions remains underexplored. Methods Using Global Burden of Diseases 2021 data, we ...
Background Benign multiple sclerosis (MS), characterised by minimal disability despite long disease duration, remains poorly understood in terms of its determinants and prognostic implications. While ...
Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei 10051, Taiwan Dr Sung-Tsang Hsieh, Department of Neurology, National Taiwan University Hospital, 7 ...
Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...
a Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute Ospedale San Raffaele, Milan, Italy, b Clinical Trials Unit Dr Massimo Filippi, Neuroimaging Research Unit, Department of ...
aDepartment of Ophthalmology, University of Alabama School of Medicine, 601 700 South 18th Street, Birmingham, Alabama, USA, bNeuro-ophthalmology Unit, University of California School of Medicine, San ...
Objective Multiple sclerosis (MS) is associated with chronic symptoms, including muscle stiffness, spasms, pain and insomnia. Here we report the results of the Multiple Sclerosis and Extract of ...
1 Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands 2 Department of Neuropathology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands Correspondence to Dr John C.
College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA Avi Ashkenazi, MD, Department of Neurology, Thomas Jefferson University, 111 South 11th ...
There have been many articles highlighting differences and similarities between complex regional pain syndrome (CRPS) and functional neurological disorders (FND) but until now the discussions have ...
Background A few case reports have shown controversial results of rituximab efficacy in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Objective To analyse the ...